近日,医药央企华润医药发布公告,将与华润医药(汕头)、华润双鹤以及华润医药投资与其他合伙人成立规模为人民币5亿元的基金。基金将主要从事合成生物学、创新药物及生物技术领域的高增长企业投资集团拟承诺出资总额将为人民币1.23亿元,约占基金承诺出资总额的24.6%。同日,华润双鹤发布公告设立“华润双鹤产业基金”,承诺出资金额不超过8300万元,约占总额的16.60%。华润并非首个布局合成生物制造的央企,...
Source Link近日,医药央企华润医药发布公告,将与华润医药(汕头)、华润双鹤以及华润医药投资与其他合伙人成立规模为人民币5亿元的基金。基金将主要从事合成生物学、创新药物及生物技术领域的高增长企业投资集团拟承诺出资总额将为人民币1.23亿元,约占基金承诺出资总额的24.6%。同日,华润双鹤发布公告设立“华润双鹤产业基金”,承诺出资金额不超过8300万元,约占总额的16.60%。华润并非首个布局合成生物制造的央企,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.